MedPage Today on MSN
Two New Malaria Treatments Show Promise as Drug Resistance Grows
Ghyslain Mombo-Ngoma, MD, PhD, led a study in Gabon in which researchers gave a single-dose treatment combining an ...
Dr. Ghyslain Mombo-Ngoma led a study in Gabon in which researchers gave a single-dose treatment combining an artemisinin with ...
NEW YORK — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to ...
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
Free Malaysia Today on MSN
2 malaria treatments show promise as drug resistance grows
A new drug called GanLum and a combination of four existing medications have been cited as potential options to treat this ...
The drug, known as GanLum, is made by Swiss pharmaceutical giant Novartis. In a late-stage trial, it worked about as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback